Inhibitors of the Epstein-Barr Virus Entry Machinery

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies

David Sidransky

Head and Neck Cancer SPORE

Other pharynx

Pathology

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Quynh-Thu Xuan Le

Targeting Galectin-1 with radiation in lung cancer

Trachea, bronchus and lung

Radiation Oncology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Non-Hodgkin lymphoma Hodgkin lymphoma

James D Marks

Antibody Research Technology Center

Nasopharynx

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma